My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2008
Vol. 18, No. 9
Global ID
Yellow Fever in Côte d'Ivoire

Nineteen cases of yellow fever have been reported in and around the city of Abidjan, Côte d’Ivoire, since May of this year, according to the U.S. Centers for Disease Control and Prevention (CDC).

A mosquito-borne viral disease, yellow fever is fatal in 15 percent to more than 50 percent of cases. Early symptoms may include fever and chills, severe headache, back pain, general muscle aches, nausea, fatigue, and weakness. Symptoms may resolve briefly then return, along with hemorrhagic symptoms such as black vomit, nose or gum bleeding, and bruising. Jaundice and proteinuria are common in severe cases. Hypotension, shock, metabolic acidosis, acute tubular necrosis, myocardial dysfunction, and cardiac arrhythmia may develop in late-stage disease, along with confusion, seizures, and coma. In those who recover, weakness and fatigue may persist for several months.

In addition to clinical symptoms and travel history, diagnosis includes blood tests for the virus, DNA, or, in later stages, antibodies. There is no specific treatment for yellow fever. Vaccination, protective clothing, and insect repellant can prevent it.

More information on the outbreak in Côte d’Ivoire is available on CDC’s Travelers’ Health webpage.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Cover Stories
CDC Campaigns Target MRSA, Inappropriate Antibiotic Use
2009 Clinical Practice Meeting in San Diego
IDSA Journal Club, August 2008
From the President
IDSA Ascendant
Patient Care and Science
EIN: Difficulty Treating Multidrug-resistant Gram Negative Infections
Drug Approvals, Recalls, Adverse Events Update
In the IDSA Journals
Practice Management
ID Physicians Have Second-highest Coding Error Rate in CMS Report
Global ID
IDSA, HIVMA Launch Infectious Diseases Center for Global Health Policy and Advocacy
Chikingunya Fever in Italy, Singapore
Q Fever in Holland
Polio Resurges in Nigeria After a Promising Year
Yellow Fever in Côte d'Ivoire
Policy and Advocacy
IDSA and HIVMA Urge Presidential Candidates to Put Science Before Politics
IDSA Advocacy Update
Education and Resources
Two New Training Grants Available For Global Research
Your Colleagues
In Memoriam: Thomas Weller
Members on the Move
Welcome, New IDSA Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.